The authors of that review article also stated that STn antigen was associated with loss of cell differentiation (cancer stem cell phenotype in this study) and that the effectiveness of the therapeutic vaccine in hormone receptor-positive patients was limited because the hormone receptor is known to be correlated with a differentiated state of cells [21]. The gene discussed is NR4A1; the disease is cancer.